ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
-1.03%
Bitcoin
62,953.49
6.48%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Codex DNA Inc (DNAY)

  7. Codex DNA Inc (DNAY) Noticias

DNAY

Codex DNA (DNAY)

Codex DNA Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:DNAY
FechaHoraFuenteTítuloSímboloCompañía
20/06/202315:11Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:DNAYCodex DNA Inc
15/06/202315:19Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:DNAYCodex DNA Inc
09/06/202315:48Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DNAYCodex DNA Inc
08/06/202317:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DNAYCodex DNA Inc
08/06/202317:10Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:DNAYCodex DNA Inc
24/05/202315:35Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:DNAYCodex DNA Inc
17/05/202315:08Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:DNAYCodex DNA Inc
19/04/202305:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DNAYCodex DNA Inc
24/03/202315:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:DNAYCodex DNA Inc
22/03/202305:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:DNAYCodex DNA Inc
14/02/202312:10Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DNAYCodex DNA Inc
09/01/202308:00GlobeNewswire Inc.Telesis Bio Pre-Announces Preliminary Fourth Quarter Financial ResultsNASDAQ:DNAYCodex DNA Inc
09/11/202205:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DNAYCodex DNA Inc
08/11/202215:10GlobeNewswire Inc.Telesis Bio Inc. Reports Third Quarter 2022 Financial ResultsNASDAQ:DNAYCodex DNA Inc
02/11/202215:19GlobeNewswire Inc.Telesis Bio to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 8NASDAQ:DNAYCodex DNA Inc
19/10/202208:00GlobeNewswire Inc.Telesis Bio and Cellibre Announce Collaboration to Optimize Development of Future BioXp® DBC instrumentNASDAQ:DNAYCodex DNA Inc
12/10/202208:00GlobeNewswire Inc.Codex DNA Announces Plan to Change Corporate Name to Telesis BioNASDAQ:DNAYCodex DNA Inc
04/10/202208:00GlobeNewswire Inc.Codex DNA Expands Application of Proprietary Error Correction TechnologyNASDAQ:DNAYCodex DNA Inc
26/09/202206:00GlobeNewswire Inc.Codex DNA Showcases Next Generation Automated Synthetic Biology Workstation at World of Technology & Science in Utrecht, NetherlandsNASDAQ:DNAYCodex DNA Inc
19/09/202206:00GlobeNewswire Inc.Codex DNA Debuts Next-Generation Automated Synthetic Biology WorkstationNASDAQ:DNAYCodex DNA Inc
22/08/202205:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:DNAYCodex DNA Inc
09/08/202215:10GlobeNewswire Inc.Codex DNA Reports Second Quarter 2022 Financial ResultsNASDAQ:DNAYCodex DNA Inc
02/08/202215:05GlobeNewswire Inc.Codex DNA to Report Second Quarter 2022 Financial Results on Tuesday, August 9, 2022NASDAQ:DNAYCodex DNA Inc
26/07/202215:13Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:DNAYCodex DNA Inc
13/06/202207:45TipRanksCodex DNA (DNAY) Receives a Rating Update from a Top AnalystNASDAQ:DNAYCodex DNA Inc
02/06/202207:03GlobeNewswire Inc.Codex DNA to Present at the 2022 Jefferies Healthcare ConferenceNASDAQ:DNAYCodex DNA Inc
01/06/202207:03GlobeNewswire Inc.Codex DNA Showcases Automated Synthetic Biology Solutions for Accelerating Discovery Workflows at the Antibody Engineering and Therapeutics Europe ConferenceNASDAQ:DNAYCodex DNA Inc
10/05/202215:05GlobeNewswire Inc.Codex DNA Reports First Quarter 2022 Financial ResultsNASDAQ:DNAYCodex DNA Inc
03/05/202207:03GlobeNewswire Inc.Codex DNA to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022NASDAQ:DNAYCodex DNA Inc
29/04/202208:20Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:DNAYCodex DNA Inc
 Showing the most relevant articles for your search:NASDAQ:DNAY

Su Consulta Reciente

NYSE
BAC
Bank of America
CCOM
SILVER
SILVER
PM
XAUUSD
Gold vs US Dollar
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLV
Health Care Select Sector
USI
USTECH100
US Tech 100
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
RHHBY
Roche (QX)
SPI
SP500
S&P 500
FX
EURUSD
Euro vs US Dollar
NYSE
XOM
Exxon Mobil
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
NVDA
NVIDIA
NYSE
NKE
Nike
AMEX
SPY
SPDR S&P 500
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados